As an extension to our current studies on new anti-HIV tannins and their analogs as well as other related natural products, the long-term objective of this research is to discover novel useful anti-HIV compounds from plant-derived natural products and their analogs. Specifically, we propose continuously to isolate and characterize the potent anti-HIV principles from extracts of 33 plant species which have never been investigated previously for their anti-HIV constituents. These extracts have already demonstrated potent inhibitory effects on HIV replication in H9 lymphocyte cells and HIV reverse transcriptase. Extraction, fractionation, and isolation of the active principles will be guided at every stage by an in vitro P24 antigen capture assay in H9 lymphocyte cells. Following the above bioassay-directed isolation of the active principles, the determination of their structures will be carried out by modern physical methods, including spectral and X-ray analyses. Mechanism of action studies will be conducted in cell culture-based assays. Structural modification and synthesis of analogs of selected new active leads in order to elucidate their structure-activity relationships, as well as to improve their pharmacological profiles will also be initiated.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Schools of Pharmacy
Chapel Hill
United States
Zip Code
Liu, Qingbo; Li, Wei; Huang, Li et al. (2018) Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui. Eur J Med Chem 156:618-627
Tian, Ye; Liu, Zhaoqiang; Liu, Jinghan et al. (2018) Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus. Eur J Med Chem 151:339-350
Huang, Li; Lai, Wei-Hong; Zhu, Lei et al. (2018) Elimination of HIV-1 Latently Infected Cells by Gnidimacrin and a Selective HDAC Inhibitor. ACS Med Chem Lett 9:268-273
Wei, Lei; Wang, Hui-Ling; Huang, Li et al. (2017) Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus. Bioorg Med Chem Lett 27:2788-2792
Dang, Zhao; Zhu, Lei; Lai, Weihong et al. (2016) Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors. ACS Med Chem Lett 7:240-4
Liu, Na; Wei, Lei; Huang, Li et al. (2016) Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus. J Med Chem 59:3689-704
Zhao, Yu; Gu, Qiong; Morris-Natschke, Susan L et al. (2016) Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1. J Med Chem 59:9262-9268
Jiang, Cheng; Luo, Pan; Zhao, Yu et al. (2016) Carolignans from the Aerial Parts of Euphorbia sikkimensis and Their Anti-HIV Activity. J Nat Prod 79:578-83
Li, Jizhen; Goto, Masuo; Yang, Xiaoming et al. (2016) Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity. Bioorg Med Chem Lett 26:68-71
Yan, Min; Lu, Yan; Chen, Chin-Ho et al. (2015) Stelleralides D-J and Anti-HIV Daphnane Diterpenes from Stellera chamaejasme. J Nat Prod 78:2712-8

Showing the most recent 10 out of 119 publications